- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medicus Pharma Ltd (MDCX)
Medicus Pharma Ltd stock price live, this page displays NASDAQ MDCX stock exchange data. View the MDCX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medicus Pharma Ltd real time stock price chart below.
What Is the Medicus Pharma Ltd Stock Price Today?
The Medicus Pharma Ltd stock price today is 1.987.
What Is the Stock Symbol for Medicus Pharma Ltd?
The stock symbol for Medicus Pharma Ltd is "MDCX."
What Stock Exchange Does Medicus Pharma Ltd Trade On?
Medicus Pharma Ltd is listed and trades on the NASDAQ stock exchange.
Is Medicus Pharma Ltd a Good Stock to Buy?
Determining whether Medicus Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDCX quote. (ISIN: CA58471K3010)
What Is the Medicus Pharma Ltd Stock Price Today?
The Medicus Pharma Ltd stock price today is 1.987.
What Is the Stock Symbol for Medicus Pharma Ltd?
The stock symbol for Medicus Pharma Ltd is "MDCX."
What Stock Exchange Does Medicus Pharma Ltd Trade On?
Medicus Pharma Ltd is listed and trades on the NASDAQ stock exchange.
Is Medicus Pharma Ltd a Good Stock to Buy?
Determining whether Medicus Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDCX quote. (ISIN: CA58471K3010)
1.987
+0.157(+8.56%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.840
2.100
52 wk Range
1.700
127.500
MDCX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8402.100
52 wk Range
1.700127.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MDCX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
203.750
Upside
+10,154.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Form 8K Medicus Pharma Ltd For: 4 November- Investing.com
Form 4 Medicus Pharma Ltd For: 6 November- Investing.com
- Form 4 Medicus Pharma Ltd For: 4 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 203.750
(+10,154.15% Upside)
Medicus Pharma Ltd Earnings Call Summary for Q3/2026
- Medicus Pharma posted Q3 2026 EPS of -$11.64 vs. -$30.50 forecast, beating by 62%, though shares fell 1.3% to $1.85 near 52-week lows.
- Company pivoting to precision oncology via Pfizer's CD228V program; Q3 operating expenses fell 5.8% to $14.5M with further cuts expected.
- Nine-month net loss widened to $35.9M from $27.3M due to $10M Pfizer deal charge; raised $42.2M capital, ending with $13.1M cash.
- SkinJect business combination with SPAC targeted for H1 2027; Teverelix product availability expected Q1 2027 with partnership pursuit ongoing.
- CFO projects substantial expense reductions ahead; stock down 98% over 12 months amid liquidity concerns and $25M liabilities vs. $13.1M cash.
Last Updated: 11/10/2026, 01:16 AM
Read Full TranscriptEarnings
Latest Release
Nov 06, 2026
EPS / Forecast
-11.64 / -30.50
Revenue / Forecast
-- / --
Compare MDCX to Peers and Sector
Metrics to compare | MDCX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMDCXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 7.1x | −0.2x | |
PEG Ratio | 0.00 | 0.03 | 0.00 | |
Price/Book | −0.2x | 1.5x | 2.6x | |
Price / LTM Sales | - | 2.7x | 2.8x | |
Upside (Analyst Target) | - | 82.5% | 60.9% | |
Fair Value Upside | Unlock | 22.2% | 9.5% | Unlock |
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Medicus Pharma (MDCX) Stock Price Today?
The Medicus Pharma stock price today is 1.987 USD.
What Stock Exchange Does Medicus Pharma Trade On?
Medicus Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Medicus Pharma?
The stock symbol for Medicus Pharma is "MDCX."
What Is the Medicus Pharma Market Cap?
As of today, Medicus Pharma market cap is 2.380M USD.
What Is Medicus Pharma's Earnings Per Share (TTM)?
The Medicus Pharma EPS (TTM) is -59.35.
From a Technical Analysis Perspective, Is MDCX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Medicus Pharma Stock Split?
Medicus Pharma has split 2 times.
What is the current trading status of Medicus Pharma (MDCX)?
As of Nov 10, 2026, Medicus Pharma (MDCX) is trading at a price of 1.987 USD, with a previous close of 1.890 USD. The stock has fluctuated within a day range of 1.840 USD to 2.100 USD, while its 52-week range spans from 1.700 USD to 127.500 USD.
What Is Medicus Pharma (MDCX) Price Target According to Analysts?
The average 12-month price target for Medicus Pharma is 203.750 USD, with a high estimate of 450 USD and a low estimate of 15 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +10,154.15% Upside potential.
What Is the MDCX Premarket Price?
MDCX's last pre-market stock price is 1.940 USD. The pre-market share volume is 80.000, and the stock has decreased by 0.050, or 2.650%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.